Cargando…
Clinical Characteristics Correlate With Outcomes of Immunotherapy in Advanced Non-Small Cell Lung Cancer
Considering the existing indicators are not sufficient to predict the patient's response to immune checkpoint inhibitors (ICIs), we conducted this study to evaluate the efficacy and safety of ICIs in advanced non-small cell lung cancer (NSCLC) patients, and to determine prognostic factors of IC...
Autores principales: | Huang, Lan, Li, Li, Zhou, Yingxu, Yang, Zhaoyang, Wang, Meng, Gao, Yina, Yang, Yang, Yang, Fang, Liu, Bao, Hong, Xuan, Chen, Gongyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646175/ https://www.ncbi.nlm.nih.gov/pubmed/33193876 http://dx.doi.org/10.7150/jca.49213 |
Ejemplares similares
-
Peripheral Tumor Location Predicts a Favorable Prognosis in Patients with Resected Small Cell Lung Cancer
por: Gao, Yina, et al.
Publicado: (2022) -
CXCL12 suppresses cisplatin-induced apoptosis through activation of JAK2/STAT3 signaling in human non-small-cell lung cancer cells
por: Wang, Meng, et al.
Publicado: (2017) -
Efficacy and safety of camrelizumab plus apatinib as second-line treatment for advanced squamous non-small cell lung cancer
por: Gao, Guanghui, et al.
Publicado: (2022) -
Imaging Biomarkers to Predict and Evaluate the Effectiveness of Immunotherapy in Advanced Non-Small-Cell Lung Cancer
por: Liu, Ying, et al.
Publicado: (2021) -
Immunotherapy and biomarkers in patients with lung cancer with tuberculosis: Recent advances and future Directions
por: Yang, Ling, et al.
Publicado: (2023)